img

Global Hematologic Malignancies Testing Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Hematologic Malignancies Testing Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Hematologic Malignancies Testing Market
Global Hematologic Malignancies Testing market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Hematologic Malignancies Testing industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Hematologic Malignancies Testing market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Hematologic Malignancies Testing market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Invitae Corporation
Bio-Rad Laboratories
Sysmex Corporation
Laboratory Corporation of America Holdings
NeoGenomics Laboratories
Abbott
VYANTbio
Adaptive Biotechnologies
Asuragen Inc.
Invivoscribe, Inc.
Segment by Type
Services
Kits

Segment by Application


Hospitals
Specialty Clinics
Research Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Hematologic Malignancies Testing introduction, etc. Hematologic Malignancies Testing Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Hematologic Malignancies Testing
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematologic Malignancies Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Services
1.2.3 Kits
1.3 Market by Application
1.3.1 Global Hematologic Malignancies Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Research Institutions
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hematologic Malignancies Testing Market Perspective (2018-2033)
2.2 Global Hematologic Malignancies Testing Growth Trends by Region
2.2.1 Hematologic Malignancies Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Hematologic Malignancies Testing Historic Market Size by Region (2018-2023)
2.2.3 Hematologic Malignancies Testing Forecasted Market Size by Region (2024-2033)
2.3 Hematologic Malignancies Testing Market Dynamics
2.3.1 Hematologic Malignancies Testing Industry Trends
2.3.2 Hematologic Malignancies Testing Market Drivers
2.3.3 Hematologic Malignancies Testing Market Challenges
2.3.4 Hematologic Malignancies Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hematologic Malignancies Testing by Players
3.1.1 Global Hematologic Malignancies Testing Revenue by Players (2018-2023)
3.1.2 Global Hematologic Malignancies Testing Revenue Market Share by Players (2018-2023)
3.2 Global Hematologic Malignancies Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hematologic Malignancies Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Hematologic Malignancies Testing Market Concentration Ratio
3.4.1 Global Hematologic Malignancies Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematologic Malignancies Testing Revenue in 2022
3.5 Global Key Players of Hematologic Malignancies Testing Head office and Area Served
3.6 Global Key Players of Hematologic Malignancies Testing, Product and Application
3.7 Global Key Players of Hematologic Malignancies Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hematologic Malignancies Testing Breakdown Data by Type
4.1 Global Hematologic Malignancies Testing Historic Market Size by Type (2018-2023)
4.2 Global Hematologic Malignancies Testing Forecasted Market Size by Type (2024-2033)
5 Hematologic Malignancies Testing Breakdown Data by Application
5.1 Global Hematologic Malignancies Testing Historic Market Size by Application (2018-2023)
5.2 Global Hematologic Malignancies Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Hematologic Malignancies Testing Market Size (2018-2033)
6.2 North America Hematologic Malignancies Testing Market Size by Type
6.2.1 North America Hematologic Malignancies Testing Market Size by Type (2018-2023)
6.2.2 North America Hematologic Malignancies Testing Market Size by Type (2024-2033)
6.2.3 North America Hematologic Malignancies Testing Market Share by Type (2018-2033)
6.3 North America Hematologic Malignancies Testing Market Size by Application
6.3.1 North America Hematologic Malignancies Testing Market Size by Application (2018-2023)
6.3.2 North America Hematologic Malignancies Testing Market Size by Application (2024-2033)
6.3.3 North America Hematologic Malignancies Testing Market Share by Application (2018-2033)
6.4 North America Hematologic Malignancies Testing Market Size by Country
6.4.1 North America Hematologic Malignancies Testing Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Hematologic Malignancies Testing Market Size by Country (2018-2023)
6.4.3 North America Hematologic Malignancies Testing Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Hematologic Malignancies Testing Market Size (2018-2033)
7.2 Europe Hematologic Malignancies Testing Market Size by Type
7.2.1 Europe Hematologic Malignancies Testing Market Size by Type (2018-2023)
7.2.2 Europe Hematologic Malignancies Testing Market Size by Type (2024-2033)
7.2.3 Europe Hematologic Malignancies Testing Market Share by Type (2018-2033)
7.3 Europe Hematologic Malignancies Testing Market Size by Application
7.3.1 Europe Hematologic Malignancies Testing Market Size by Application (2018-2023)
7.3.2 Europe Hematologic Malignancies Testing Market Size by Application (2024-2033)
7.3.3 Europe Hematologic Malignancies Testing Market Share by Application (2018-2033)
7.4 Europe Hematologic Malignancies Testing Market Size by Country
7.4.1 Europe Hematologic Malignancies Testing Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Hematologic Malignancies Testing Market Size by Country (2018-2023)
7.4.3 Europe Hematologic Malignancies Testing Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hematologic Malignancies Testing Market Size (2018-2033)
8.2 China Hematologic Malignancies Testing Market Size by Type
8.2.1 China Hematologic Malignancies Testing Market Size by Type (2018-2023)
8.2.2 China Hematologic Malignancies Testing Market Size by Type (2024-2033)
8.2.3 China Hematologic Malignancies Testing Market Share by Type (2018-2033)
8.3 China Hematologic Malignancies Testing Market Size by Application
8.3.1 China Hematologic Malignancies Testing Market Size by Application (2018-2023)
8.3.2 China Hematologic Malignancies Testing Market Size by Application (2024-2033)
8.3.3 China Hematologic Malignancies Testing Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Hematologic Malignancies Testing Market Size (2018-2033)
9.2 Asia Hematologic Malignancies Testing Market Size by Type
9.2.1 Asia Hematologic Malignancies Testing Market Size by Type (2018-2023)
9.2.2 Asia Hematologic Malignancies Testing Market Size by Type (2024-2033)
9.2.3 Asia Hematologic Malignancies Testing Market Share by Type (2018-2033)
9.3 Asia Hematologic Malignancies Testing Market Size by Application
9.3.1 Asia Hematologic Malignancies Testing Market Size by Application (2018-2023)
9.3.2 Asia Hematologic Malignancies Testing Market Size by Application (2024-2033)
9.3.3 Asia Hematologic Malignancies Testing Market Share by Application (2018-2033)
9.4 Asia Hematologic Malignancies Testing Market Size by Region
9.4.1 Asia Hematologic Malignancies Testing Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Hematologic Malignancies Testing Market Size by Region (2018-2023)
9.4.3 Asia Hematologic Malignancies Testing Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Invitae Corporation
11.1.1 Invitae Corporation Company Details
11.1.2 Invitae Corporation Business Overview
11.1.3 Invitae Corporation Hematologic Malignancies Testing Introduction
11.1.4 Invitae Corporation Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.1.5 Invitae Corporation Recent Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Hematologic Malignancies Testing Introduction
11.2.4 Bio-Rad Laboratories Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Developments
11.3 Sysmex Corporation
11.3.1 Sysmex Corporation Company Details
11.3.2 Sysmex Corporation Business Overview
11.3.3 Sysmex Corporation Hematologic Malignancies Testing Introduction
11.3.4 Sysmex Corporation Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.3.5 Sysmex Corporation Recent Developments
11.4 Laboratory Corporation of America Holdings
11.4.1 Laboratory Corporation of America Holdings Company Details
11.4.2 Laboratory Corporation of America Holdings Business Overview
11.4.3 Laboratory Corporation of America Holdings Hematologic Malignancies Testing Introduction
11.4.4 Laboratory Corporation of America Holdings Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.4.5 Laboratory Corporation of America Holdings Recent Developments
11.5 NeoGenomics Laboratories
11.5.1 NeoGenomics Laboratories Company Details
11.5.2 NeoGenomics Laboratories Business Overview
11.5.3 NeoGenomics Laboratories Hematologic Malignancies Testing Introduction
11.5.4 NeoGenomics Laboratories Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.5.5 NeoGenomics Laboratories Recent Developments
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Hematologic Malignancies Testing Introduction
11.6.4 Abbott Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.6.5 Abbott Recent Developments
11.7 VYANTbio
11.7.1 VYANTbio Company Details
11.7.2 VYANTbio Business Overview
11.7.3 VYANTbio Hematologic Malignancies Testing Introduction
11.7.4 VYANTbio Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.7.5 VYANTbio Recent Developments
11.8 Adaptive Biotechnologies
11.8.1 Adaptive Biotechnologies Company Details
11.8.2 Adaptive Biotechnologies Business Overview
11.8.3 Adaptive Biotechnologies Hematologic Malignancies Testing Introduction
11.8.4 Adaptive Biotechnologies Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.8.5 Adaptive Biotechnologies Recent Developments
11.9 Asuragen Inc.
11.9.1 Asuragen Inc. Company Details
11.9.2 Asuragen Inc. Business Overview
11.9.3 Asuragen Inc. Hematologic Malignancies Testing Introduction
11.9.4 Asuragen Inc. Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.9.5 Asuragen Inc. Recent Developments
11.10 Invivoscribe, Inc.
11.10.1 Invivoscribe, Inc. Company Details
11.10.2 Invivoscribe, Inc. Business Overview
11.10.3 Invivoscribe, Inc. Hematologic Malignancies Testing Introduction
11.10.4 Invivoscribe, Inc. Revenue in Hematologic Malignancies Testing Business (2018-2023)
11.10.5 Invivoscribe, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hematologic Malignancies Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Services
Table 3. Key Players of Kits
Table 4. Global Hematologic Malignancies Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Hematologic Malignancies Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Hematologic Malignancies Testing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Hematologic Malignancies Testing Market Share by Region (2018-2023)
Table 8. Global Hematologic Malignancies Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Hematologic Malignancies Testing Market Share by Region (2024-2033)
Table 10. Hematologic Malignancies Testing Market Trends
Table 11. Hematologic Malignancies Testing Market Drivers
Table 12. Hematologic Malignancies Testing Market Challenges
Table 13. Hematologic Malignancies Testing Market Restraints
Table 14. Global Hematologic Malignancies Testing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Hematologic Malignancies Testing Revenue Share by Players (2018-2023)
Table 16. Global Top Hematologic Malignancies Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Testing as of 2022)
Table 17. Global Hematologic Malignancies Testing Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Hematologic Malignancies Testing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Hematologic Malignancies Testing, Headquarters and Area Served
Table 20. Global Key Players of Hematologic Malignancies Testing, Product and Application
Table 21. Global Key Players of Hematologic Malignancies Testing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hematologic Malignancies Testing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Hematologic Malignancies Testing Revenue Market Share by Type (2018-2023)
Table 25. Global Hematologic Malignancies Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Hematologic Malignancies Testing Revenue Market Share by Type (2024-2033)
Table 27. Global Hematologic Malignancies Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Hematologic Malignancies Testing Revenue Share by Application (2018-2023)
Table 29. Global Hematologic Malignancies Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Hematologic Malignancies Testing Revenue Share by Application (2024-2033)
Table 31. North America Hematologic Malignancies Testing Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Hematologic Malignancies Testing Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Hematologic Malignancies Testing Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Hematologic Malignancies Testing Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Hematologic Malignancies Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Hematologic Malignancies Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Hematologic Malignancies Testing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Hematologic Malignancies Testing Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Hematologic Malignancies Testing Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Hematologic Malignancies Testing Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Hematologic Malignancies Testing Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Hematologic Malignancies Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Hematologic Malignancies Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Hematologic Malignancies Testing Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Hematologic Malignancies Testing Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Hematologic Malignancies Testing Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Hematologic Malignancies Testing Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Hematologic Malignancies Testing Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Hematologic Malignancies Testing Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Hematologic Malignancies Testing Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Hematologic Malignancies Testing Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Hematologic Malignancies Testing Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Hematologic Malignancies Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Hematologic Malignancies Testing Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Hematologic Malignancies Testing Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Hematologic Malignancies Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size by Country (2024-2033) & (US$ Million)
Table 63. Invitae Corporation Company Details
Table 64. Invitae Corporation Business Overview
Table 65. Invitae Corporation Hematologic Malignancies Testing Product
Table 66. Invitae Corporation Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 67. Invitae Corporation Recent Developments
Table 68. Bio-Rad Laboratories Company Details
Table 69. Bio-Rad Laboratories Business Overview
Table 70. Bio-Rad Laboratories Hematologic Malignancies Testing Product
Table 71. Bio-Rad Laboratories Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 72. Bio-Rad Laboratories Recent Developments
Table 73. Sysmex Corporation Company Details
Table 74. Sysmex Corporation Business Overview
Table 75. Sysmex Corporation Hematologic Malignancies Testing Product
Table 76. Sysmex Corporation Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 77. Sysmex Corporation Recent Developments
Table 78. Laboratory Corporation of America Holdings Company Details
Table 79. Laboratory Corporation of America Holdings Business Overview
Table 80. Laboratory Corporation of America Holdings Hematologic Malignancies Testing Product
Table 81. Laboratory Corporation of America Holdings Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 82. Laboratory Corporation of America Holdings Recent Developments
Table 83. NeoGenomics Laboratories Company Details
Table 84. NeoGenomics Laboratories Business Overview
Table 85. NeoGenomics Laboratories Hematologic Malignancies Testing Product
Table 86. NeoGenomics Laboratories Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 87. NeoGenomics Laboratories Recent Developments
Table 88. Abbott Company Details
Table 89. Abbott Business Overview
Table 90. Abbott Hematologic Malignancies Testing Product
Table 91. Abbott Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 92. Abbott Recent Developments
Table 93. VYANTbio Company Details
Table 94. VYANTbio Business Overview
Table 95. VYANTbio Hematologic Malignancies Testing Product
Table 96. VYANTbio Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 97. VYANTbio Recent Developments
Table 98. Adaptive Biotechnologies Company Details
Table 99. Adaptive Biotechnologies Business Overview
Table 100. Adaptive Biotechnologies Hematologic Malignancies Testing Product
Table 101. Adaptive Biotechnologies Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 102. Adaptive Biotechnologies Recent Developments
Table 103. Asuragen Inc. Company Details
Table 104. Asuragen Inc. Business Overview
Table 105. Asuragen Inc. Hematologic Malignancies Testing Product
Table 106. Asuragen Inc. Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 107. Asuragen Inc. Recent Developments
Table 108. Invivoscribe, Inc. Company Details
Table 109. Invivoscribe, Inc. Business Overview
Table 110. Invivoscribe, Inc. Hematologic Malignancies Testing Product
Table 111. Invivoscribe, Inc. Revenue in Hematologic Malignancies Testing Business (2018-2023) & (US$ Million)
Table 112. Invivoscribe, Inc. Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hematologic Malignancies Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Hematologic Malignancies Testing Market Share by Type: 2022 VS 2033
Figure 3. Services Features
Figure 4. Kits Features
Figure 5. Global Hematologic Malignancies Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Hematologic Malignancies Testing Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Research Institutions Case Studies
Figure 10. Others Case Studies
Figure 11. Hematologic Malignancies Testing Report Years Considered
Figure 12. Global Hematologic Malignancies Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Hematologic Malignancies Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Hematologic Malignancies Testing Market Share by Region: 2022 VS 2033
Figure 15. Global Hematologic Malignancies Testing Market Share by Players in 2022
Figure 16. Global Top Hematologic Malignancies Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Testing as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Hematologic Malignancies Testing Revenue in 2022
Figure 18. North America Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Hematologic Malignancies Testing Market Share by Type (2018-2033)
Figure 20. North America Hematologic Malignancies Testing Market Share by Application (2018-2033)
Figure 21. North America Hematologic Malignancies Testing Market Share by Country (2018-2033)
Figure 22. United States Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Hematologic Malignancies Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Hematologic Malignancies Testing Market Share by Type (2018-2033)
Figure 26. Europe Hematologic Malignancies Testing Market Share by Application (2018-2033)
Figure 27. Europe Hematologic Malignancies Testing Market Share by Country (2018-2033)
Figure 28. Germany Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Hematologic Malignancies Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Hematologic Malignancies Testing Market Share by Type (2018-2033)
Figure 36. China Hematologic Malignancies Testing Market Share by Application (2018-2033)
Figure 37. Asia Hematologic Malignancies Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Hematologic Malignancies Testing Market Share by Type (2018-2033)
Figure 39. Asia Hematologic Malignancies Testing Market Share by Application (2018-2033)
Figure 40. Asia Hematologic Malignancies Testing Market Share by Region (2018-2033)
Figure 41. Japan Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Hematologic Malignancies Testing Market Share by Country (2018-2033)
Figure 51. Brazil Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Hematologic Malignancies Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Invitae Corporation Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 59. Sysmex Corporation Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 60. Laboratory Corporation of America Holdings Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 61. NeoGenomics Laboratories Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 62. Abbott Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 63. VYANTbio Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 64. Adaptive Biotechnologies Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 65. Asuragen Inc. Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 66. Invivoscribe, Inc. Revenue Growth Rate in Hematologic Malignancies Testing Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries